Company / Inventory
ANI Pharmaceuticals, Inc. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$143.1M
FY2025
5-year range
$81.7M / $143.1M
FY2021-FY2025
Trend
+4.6%
vs FY2024
Sector context
#37 of 105
Health Care
What the data says
At $143M, ANI Pharmaceuticals, Inc.'s inventory ranks #37 of 105 in the Health Care sector. Inventory has increased for 9 consecutive years, from $26M in FY2016 to $143M in FY2025.
Based on SEC 10-K filings.
$143M in FY2025 with a 5-year CAGR of +18.7%.
Improved from $111M to $143M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +10.7%
- 5-Year CAGR
- +18.7%
- 10-Year CAGR
- -
Sector benchmark
#37 of 105 in Health CareTop 35% of 105This company $143.1M Sector average $885.3M
▼
-83.8% below sector average
Key checks
Key Insights
- ANI Pharmaceuticals, Inc.'s inventory has grown for 9 consecutive years.
- 5-year CAGR of +18.7%, indicating consistent growth.
- In FY2025, inventory increased 4.6% year-over-year.
- Ranks #37 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $143.1M | +4.6% |
| FY2024 | $136.8M | +23.0% |
| FY2023 | $111.2M | +5.5% |
| FY2022 | $105.4M | +29.0% |
| FY2021 | $81.7M | +34.4% |
| FY2020 | $60.8M | +26.2% |
| FY2019 | $48.2M | +18.9% |
| FY2018 | $40.5M | +7.4% |
| FY2017 | $37.7M | +44.1% |
| FY2016 | $26.2M | +95.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026